LFB SA Board of Directors

Composition of the LFB SA Board of Directors.

French government representative (appointed by decree)

Cédric GARCIN

Responsible for investments at the Government Investments Agency (APE)

Members of the Board appointed by the General Assembly, proposed by French State:

Denis DELVAL*

CEO of LFB SA, CEO of LFB BIOMEDICAMENTS SA, and of LFB BIOTECHNOLOGIES,

Pierre ANGOT

Deputy Director of Chemistry, Materials and Eco-Industries, Department of Business, French Ministry of the Economy and Finance

Pascale AUGÉ

Chair of the Executive Board, INSERM TRANSFERT SA

François AUVIGNE

Inspector Gen. of Taxes, IFG, Ministry of the Economy and Finance

Corinne FAU

Member of the Board and Chief Financial Officer for Enedis

Members of the Board representing employees (elected)

Dominique SAINT PICQ

Change Control Coordinator– LFB BIOMEDICAMENTS SA

Wilhelmus STEVENS

Plasma proteins’ program Director – LFB BIOTECHNOLOGIES SA

Jérôme WACRENIER

IT industrial engineer – LFB BIOMEDICAMENTS SA

Guests:

Government commissioner:

Anne-Claire AMPROU, Deputy Director-General for Health, Ministry of Health

Financial and Economic auditors:

Gérard BELET, Marc GAZAVE

* Denis DELVAL is appointed acting Chief Executive Officer of LFB SA, on the 4th December 2017, by a letter from the Ministry, dated 4th December. This letter puts an end to the mandate of Christian BECHON following the article 21 of the Order dated 20th August 2014. The Board of Directors of LFB SA, gathered on the 4th December 2017, proposed to appoint Denis DELVAL as the new CEO of LFB SA in accordance with the provisions set forth in article 19 of the Order dated 20th August 2014 – The decree appointing Denis DELVAL will be published later on.